^
CANCER:

Colorectal Adenocarcinoma

Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related cancers:
MSI-H/dMMR
Colorectal Adenocarcinoma
nivolumab + ipilimumab
Sensitive
:
C1
PIK3CA V955G
Colorectal Adenocarcinoma
cetuximab
Resistant
:
C3
ALK fusion
Colorectal Adenocarcinoma
ceritinib
Sensitive
:
C3
KRAS mutation
Colorectal Adenocarcinoma
ceritinib
Resistant
:
C3
EWSR1 mutation
Colorectal Adenocarcinoma
sintilimab + fruquintinib
Resistant
:
C3
PD-L2 overexpression
Colorectal Adenocarcinoma
PD-L1 inhibitor + PD-L2 inhibitor
Sensitive
:
D
KRAS G13D
Colorectal Adenocarcinoma
ASN007
Sensitive
:
D
APC mutation
Colorectal Adenocarcinoma
ST316
Sensitive
:
D